⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1785359 | 1.00 | — | — | |
| SCHEMBL1785357 | 1.00 | — | — | |
| SCHEMBL11177677 | 0.87 | ALDH1A1 (0.45) | — | |
| SCHEMBL11177674 | 0.87 | ALDH1A1 (0.45) | — | |
| SCHEMBL11705127 | 0.76 | — | — | |
| SCHEMBL1915003 | 0.76 | — | — | |
| SCHEMBL1915004 | 0.76 | — | — | |
| SCHEMBL19546224 | 0.73 | — | — | |
| SCHEMBL21546285 | 0.73 | — | — | |
| SCHEMBL2436977 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240358016-A1 | Antimicrobial Compositions for Modulation of Fruit and Vegetable Tissue Necrosis | JENEIL BIOSURFACTANT CO LLC (US) | 2024-10-31 | — | — | US | disclosed |
| US-12063928-B2 | Antimicrobial compositions for modulation of fruit and vegetable tissue necrosis | JENEIL BIOSURFACTANT COMPANY, LLC (US) | 2024-08-20 | — | — | US | disclosed |
| US-20230322704-A1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS, INC. | 2023-10-12 | — | — | US | disclosed |
| US-20210235696-A1 | Antimicrobial Compositions for Modulation of Fruit and Vegetable Tissue Necrosis | JENEIL BIOSURFACTANT COMPANY, LLC | 2021-08-05 | — | — | US | disclosed |
| US-10017491-B2 | Compounds and uses thereof for the modulation of hemoglobin | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2018-07-10 | — | — | US | disclosed |
| US-20180186807-A1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | BIOPHARMA CREDIT PLC (GB) | 2018-07-05 | — | — | US | disclosed |
| US-9981939-B2 | Compounds and uses thereof for the modulation of hemoglobin | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2018-05-29 | — | — | US | disclosed |
| US-20170174654-A1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS, INC. | 2017-06-22 | — | — | US | disclosed |
| US-9422279-B2 | Compounds and uses thereof for the modulation of hemoglobin | GLOBAL BLOOD THERAPEUTICS, INC. (US) | 2016-08-23 | — | — | US | disclosed |
| US-20160083343-A1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | Global Blood Therapeutics, Inc (US) | 2016-03-24 | — | — | US | disclosed |
| US-20150141465-A1 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | GLOBAL BLOOD THERAPEUTICS, INC. | 2015-05-21 | — | — | US | disclosed |
| US-20140275152-A1 | Compounds and uses thereof for the modulation of hemoglobin | GLOBAL BLOOD THERAPEUTICS, INC. | 2014-09-18 | — | — | US | disclosed |